Finance

Lists
VIRP:EPA
Virbac SA
€312.00
+1.63%
(+5.00) 1D
Oct 6, 5:35:15 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VIRP...
Open
€310.50
High
€315.50
Low
€310.00
Mkt. cap
2.61B
Avg. vol.
6.23K
Volume
2.83K
P/E ratio
16.79
52-wk high
€389.50
52-wk low
€297.00
EPS
€18.58
Shares outstanding
8.39M
No. of employees
6K
Open
€310.50
High
€315.50
Low
€310.00
Mkt. cap
2.61B
Avg. vol.
6.23K
Volume
2.83K
P/E ratio
16.79
52-wk high
€389.50
52-wk low
€297.00
EPS
€18.58
Shares outstanding
8.39M
No. of employees
6K
News stories
From web sources and news partners
Profile
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick. The company is the world’s 6th largest veterinarian pharmaceutical group with a turnover of 1,465 million euros in 2025. The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME. Wikipedia
About Virbac SA
CEO-
Employees6.44K
Founded1968
HeadquartersCarros, Provence-Alpes-Côte d'Azur, France
SectorPharmaceutical industry
Last report
Jul 20, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
383.98M / 385.00M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
363.20M
363.20M
383.98M
383.98M
Cost of goods sold
123.55M
123.55M
121.46M
121.46M
Cost of revenue
123.55M
123.55M
121.46M
121.46M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
173.95M
173.95M
172.56M
172.56M
Operating expense
190.71M
190.71M
193.05M
193.05M
Total operating expenses
314.27M
314.27M
314.52M
314.52M
Operating income
48.93M
48.93M
69.46M
69.46M
Other non operating income
-120.00K
-120.00K
202.00K
202.00K
EBT including unusual items
46.85M
46.85M
65.10M
65.10M
EBT excluding unusual items
48.90M
48.90M
67.92M
67.92M
Income tax expense
12.74M
12.74M
21.54M
21.54M
Effective tax rate
27.19%
27.19%
33.09%
33.09%
Other operating expenses
1.93M
1.93M
3.38M
3.38M
Net income
34.24M
34.24M
43.69M
43.69M
Net profit margin
9.43%
9.43%
11.38%
11.38%
Earnings per share
-
-
-
-
Interest and investment income
1.15M
1.15M
1.04M
1.04M
Interest expense
-1.92M
-1.92M
-2.13M
-2.13M
Net interest expenses
-764.50K
-764.50K
-1.09M
-1.09M
Depreciation and amortization charges
13.77M
13.77M
14.44M
14.44M
EBITDA
60.18M
60.18M
85.76M
85.76M
Gain or loss from assets sale
505.50K
505.50K
1.70M
1.70M
AI content may include mistakes. Learn more
Google apps